Filing Flows › Elite Pharmaceuticals (ELTP) › How it makes money
How Elite Pharmaceuticals (ELTP) makes money
Elite Pharmaceuticals (ELTP) made $32.4M of revenue in the first quarter fiscal 2027 (Q1 FY27), -20% from a year earlier. Abbreviated New Drug Applications Revenue brought in $32.1M (99%); Licensing brought in $221K (1%). Of every dollar of revenue, 42¢ was left as gross profit, 23¢ was left as operating profit, 18¢ was left as net earnings.
Drawing the Sankey…
Revenue by segment, Q1 FY27
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Abbreviated New Drug Applications Revenue | $32.1M | 99.3% | — | -19% |
| ↳ Direct Sales to Wholesalers | $16.4M | 50.7% | — | -14% |
| ↳ Indirect Sales to Wholesalers | $15.7M | 48.6% | — | -24% |
| Licensing | $221K | 0.7% | — | -49% |
Where each dollar of revenue goes
| Line | Q1 FY27 | % of revenue |
|---|---|---|
| Revenue | $32.4M | 100.0% |
| Cost of revenue | $18.8M | 58.3% |
| Gross profit | $13.5M | 41.7% |
| Operating expenses | $6.0M | 18.5% |
| Operating profit | $7.5M | 23.3% |
| Income tax | $1.8M | 5.6% |
| Net earnings | $5.9M | 18.3% |
| Operating cash flow | $10.1M | 31.1% |
| Free cash flow | $9.3M | 28.6% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q1 FY27 | $32.4M | -20% |
| Q4 FY26 | $40.7M | +27% |
| Q3 FY26 | $31.6M | +120% |
| Q2 FY26 | $36.3M | +92% |
| Q1 FY26 | $40.2M | +114% |
| Q4 FY25 | $32.0M | +78% |
| Q3 FY25 | $14.4M | -8% |
From Elite Pharmaceuticals' 10-Q filed Aug 13, 2026 (on EDGAR).
Questions
How does Elite Pharmaceuticals make money?
Elite Pharmaceuticals (ELTP) made $32.4M of revenue in the first quarter fiscal 2027 (Q1 FY27), -20% from a year earlier. Abbreviated New Drug Applications Revenue brought in $32.1M (99%); Licensing brought in $221K (1%). Of every dollar of revenue, 42¢ was left as gross profit, 23¢ was left as operating profit, 18¢ was left as net earnings.
What is Elite Pharmaceuticals' biggest business?
Abbreviated New Drug Applications Revenue: $32.1M in the first quarter fiscal 2027, 99% of revenue, -19% from a year earlier.
What is Elite Pharmaceuticals' profit margin?
Net earnings were $5.9M, 18.3% of revenue, in the first quarter fiscal 2027; the operating margin was 23.3%.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.